COVID-19: Convalescent plasma as a potential therapy.

Van den Berg, K; Vermeulen, M; Glatt, T N; Wasserman, S; Barrett, C L; Peter, J; Brittain, D; Louw, V J

Van den Berg, K; Vermeulen, M; Glatt, T N; Wasserman, S; Barrett, C L; Peter, J; Brittain, D; Louw, V J.

Van den Berg K; Translational Research, Medical Division, South African National Blood Service, Roodepoort, South Africa; Division of Clinical Haematology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa. karin.vandenberg@sanbs.org.za.

S Afr Med J ; 110(7): 562-563, 2020 06 04.

Article in English | MEDLINE | ID: covidwho-743585

Subject(s)

Coronavirus Infections/epidemiology; Coronavirus Infections/therapy; Pandemics/statistics & numerical data; Pneumonia, Viral/epidemiology; Pneumonia, Viral/therapy; COVID-19; Developing Countries; Female; Follow-Up Studies; Humans; Immunization, Passive/methods; Male; Risk Assessment; South Africa; Survival Analysis; Treatment Outcome; COVID-19 Serotherapy

Search on Google

XML

PubMed Links

Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics Type of study: Cohort study / Observational study / Prognostic study Limits: Female / Humans / Male Country/Region as subject: Africa Language: English Journal: S Afr Med J Year: 2020 Document Type: Article Affiliation country: South Africa

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

PubMed Links